Bio-Techne Corporation

Bio-Techne Corporationverified

TECH

Price:

$73.03

Market Cap:

$11.60B

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of ma...[Read more]

Industry

Biotechnology

IPO Date

1989-02-09

Stock Exchange

NASDAQ

Ticker

TECH

The Enterprise Value as of December 2024 (TTM) for Bio-Techne Corporation (TECH) is 11.82B

According to Bio-Techne Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 11.82B. This represents a change of -2.17% compared to the average of 12.08B of the last 4 quarters.

Bio-Techne Corporation (TECH) Historical Enterprise Value (quarterly & annually)

How has TECH Enterprise Value performed in the past?

The mean historical Enterprise Value of Bio-Techne Corporation over the last ten years is 9.32B. The current 11.82B Enterprise Value has changed 12.58% with respect to the historical average. Over the past ten years (40 quarters), TECH's Enterprise Value was at its highest in in the December 2021 quarter at 20.48B. The Enterprise Value was at its lowest in in the December 2015 quarter at 3.45B.

Quarterly (TTM)
Annual

Average

9.32B

Median

9.34B

Minimum

3.71B

Maximum

17.67B

Bio-Techne Corporation (TECH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bio-Techne Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 70.30%

Maximum Annual Enterprise Value = 17.67B

Minimum Annual Increase = -22.19%

Minimum Annual Enterprise Value = 3.71B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202411.56B-11.78%
202313.10B-4.68%
202213.75B-22.19%
202117.67B70.30%
202010.38B24.83%
20198.31B44.24%
20185.76B24.09%
20174.64B8.91%
20164.26B14.77%
20153.71B19.49%

Bio-Techne Corporation (TECH) Average Enterprise Value

How has TECH Enterprise Value performed in the past?

The current Enterprise Value of Bio-Techne Corporation (TECH) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

12.80B

5-year avg

13.29B

10-year avg

9.32B

Bio-Techne Corporation (TECH) Enterprise Value vs. Peers

How is TECH’s Enterprise Value compared to its peers?

Bio-Techne Corporation’s Enterprise Value is less than BioMarin Pharmaceutical Inc. (12.63B), greater than Vaxcyte, Inc. (9.69B), greater than Liquidia Corporation (774.18M), greater than Legend Biotech Corporation (5.90B), less than Seagen Inc. (42.84B), less than Alnylam Pharmaceuticals, Inc. (31.58B), greater than Exelixis, Inc. (9.59B), greater than Halozyme Therapeutics, Inc. (7.40B), greater than Replimune Group, Inc. (904.39M), greater than Nuvalent, Inc. (5.50B), greater than Ventyx Biosciences, Inc. (109.78M), greater than Ascendis Pharma A/S (8.13B), less than United Therapeutics Corporation (14.96B), greater than Apellis Pharmaceuticals, Inc. (4.22B), less than BeiGene, Ltd. (18.46B), greater than Akero Therapeutics, Inc. (1.71B), greater than Blueprint Medicines Corporation (6.13B), greater than Travere Therapeutics, Inc. (1.86B),

Build a custom stock screener for Bio-Techne Corporation (TECH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Techne Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bio-Techne Corporation (TECH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bio-Techne Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Bio-Techne Corporation's Enterprise Value?

What is the highest Enterprise Value for Bio-Techne Corporation (TECH)?

What is the 3-year average Enterprise Value for Bio-Techne Corporation (TECH)?

What is the 5-year average Enterprise Value for Bio-Techne Corporation (TECH)?

How does the current Enterprise Value for Bio-Techne Corporation (TECH) compare to its historical average?